Osteopore (ASX:OSX) Long-Term Debt: A$1.41 Mil (As of Dec. 2025)


What is Osteopore Long-Term Debt?

Osteopore ASX:OSX +25.00% Long-Term Debt is A$1.41 Mil as of Dec. 2025. The stock has 7 warning signs investors should review.

Osteopore's Long-Term Debt for the quarter that ended in Dec. 2025 was A$1.41 Mil.

Osteopore's quarterly Long-Term Debt increased from Dec. 2024 (A$0.00 Mil) to Jun. 2025 (A$1.61 Mil) but then declined from Jun. 2025 (A$1.61 Mil) to Dec. 2025 (A$1.41 Mil).

Osteopore's annual Long-Term Debt stayed the same from Dec. 2023 (A$0.00 Mil) to Dec. 2024 (A$0.00 Mil) but then increased from Dec. 2024 (A$0.00 Mil) to Dec. 2025 (A$1.41 Mil).

Osteopore  (ASX:OSX) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Osteopore Long-Term Debt Related Terms

Osteopore Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Osteopore's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Osteopore Long-Term Debt Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 1.41

Osteopore Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.01 0.00 1.61 1.41
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$1.41 Mil mean?
Osteopore (ASX:OSX) has a Long-Term Debt of A$1.41 Mil as of Dec. 2025.
Is Osteopore's Long-Term Debt too high?
Osteopore's current Long-Term Debt is A$1.41 Mil.
How does Osteopore's Long-Term Debt compare to ISRG and BDX?
Osteopore's Long-Term Debt of A$1.41 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Osteopore's current Long-Term Debt is A$1.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Osteopore stock overvalued right now?
Based on GuruFocus' analysis, Osteopore (ASX:OSX) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.02, compared to a current price of A$0.01 — trading 75% below its estimated fair value. The current Long-Term Debt is A$1.41 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Osteopore (ASX:OSX), the current Long-Term Debt is A$1.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Osteopore Business Description

Address 2 Tukang Innovation Grove, No. 09-06 and 07, JTC MedTech Hub, Singapore, SGP, 618305
Osteopore Ltd is engaged in the production of 3D-printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery, and Osteomesh which is a bioresorbable implant used in craniofacial surgery. It operate in the high-growth regenerative medicine sector, where adoption continues to rise as healthcare systems increasingly embrace developed tissue-regenerative solutions. Business operating segments are based on the firm's geographical presence in Singapore and Australia.